Tapemark Competitors and Similar CompaniesClear all

Tapemark's competitors and similar companies include Hansoh Pharma, PPD and WuXi Biologics.

	Tapemark Tapemark (also known as LTS Therapy Systems) is a company specializing in the development and manufacturing of transdermal, oral thin film, and unit dose semi-solid drug delivery.	Hansoh Pharma Hansoh Pharmaceutical Group (翰森制药集团总) is a biopharmaceutical company.	PPD PPD (Pharmaceutical Product Development) is a company that provides drug development and laboratory solutions.	WuXi Biologics WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development.
Founding Date	Founding Date 1952	Founding Date 1995	Founding Date 1985	Founding Date 2010
Type	Type Subsidiary	Type Public	Type Subsidiary	Type Public
Tags	Tags Manufacturing & Industrial biotech drug development	Tags Manufacturing & Industrial biotech drug development pharma	Tags Manufacturing & Industrial clinical research drug development pharma	Tags Manufacturing & Industrial biotech drug development pharma
Locations	Locations Saint Paul, US HQ	Locations Shanghai, CN HQ	Locations Wilmington, US HQ Buenos Aires, AR Melbourne, AU Brussels, BE Zaventem, BE São Paulo, BR São Paulo, BR see more	Locations Wuxi, CN HQ George Town, KY Wuppertal, DE Hong Kong, HK Dundalk, IE Cranbury, US King Of Prussia, US
Employees	Employees 522% decrease	Employees 8,989	Employees 24,5842% decrease	Employees 12,575
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $4.7b (FY, 2020)	Revenue (est.) ¥21.8b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $1.7b (FY, 2020)	Cost of goods ¥10b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $3b (FY, 2020)	Gross profit ¥12b (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income $160.6m (FY, 2020)	Net income ¥5.7b (FY, 2025)
Operating ⚠
Backlog	Backlog N/A	Backlog N/A	Backlog $9.5b (Q3, 2021)	Backlog $18.5b (H1, 2022)